ArticleScientific reports2025
A study on the cellular adhesion properties of a hybrid scaffold for vascular tissue engineering through molecular dynamics simulation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Laser-Engineered Multilayer Coatings Based on Zinc Oxide and Lovastatin-Functionalized Bioactive Glasses for Corrosion-Resistant and Antimicrobial Stainless Steel Implants.Biomimetics (Basel, Switzerland) · 2026Article
- Calcium-enriched mesoporous silica/PLGA scaffolds enhance bone repair in a rabbit femoral condylar defect model.Scientific reports · 2026Article
- Enhanced Cell Adhesion on Biofunctionalized Ti6Al4V Alloy: Immobilization of Proteins and Biomass fromInternational journal of molecular sciences · 2026Article
- Emerging 4D Fabrication of Tubular Structures and Clinical Challenges: Critical Perspective.ACS materials Au · 2025Review
- Fabrication of a low-kink-radius bilayer vascular scaffold incorporating a TPU stent fabricated via melt electrowriting and an electrospun PCL/PU/gelatin layer.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Utilizing biocompatible hybrid scaffolds that promote cell adhesion and proliferation is critically significant in the field of tissue engineering. In order to achieve this goal, the composition of polymers in the sample should be adjusted accordingly In this research, molecular dynamics simulations are utilized to investigate how the composition of blends influences the protein adsorption properties of hybrid scaffolds. Scaffolds considered here consist of Bombyx mori silk fibroin (B. mori SF) and thermoplastic polyurethane (TPU) intended for application in vascular grafts. Three different compositions are investigated in this study: One sample with 70% TPU by volume (SF:TPU-3/7), the second sample with 50% TPU (SF:TPU-1/1) and the last sample with 30% TPU (SF:TPU-7/3). The interaction between the polymeric scaffold surfaces and fibronectin and laminin, two major proteins found in vascular tissues, is studied using molecular dynamics simulations. The biocompatibility of each sample is examined based on calculated adhesion energy and final protein conformation. Furthermore, MTT cell viability, cell adhesion, and live/dead assays are performed to validate the simulation results. Third-passage human umbilical vein cell (HUVEC) is utilized in this study. The simulations revealed that B. mori SF (SF) content in the blend needs to be balanced with TPU to enhance the protein adsorption strength. The experimental results exhibited a correlation with the simulations and were verified with cell adhesion and staining assays. The SF:TPU-1/1 had the highest cell viability followed by SF:TPU-7/3 and SF:TPU-3/7 with [Formula: see text], [Formula: see text], and [Formula: see text], respectively, demonstrating the accuracy of the simulations and the possibility of predicting the biocompatibility of biomaterials through simulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.